Point72 Hong Kong’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,526
Closed -$338K 1079
2022
Q3
$338K Sell
28,526
-13,799
-33% -$209K 0.01% 902
2022
Q2
$646K Buy
42,325
+10,268
+32% +$185K 0.02% 650
2022
Q1
$678K Buy
+32,057
New +$691K 0.02% 624
2021
Q4
Sell
-8,148
Closed -$164K 2197
2021
Q3
$164K Buy
+8,148
New +$167K 0.01% 1227
2021
Q1
Sell
-10,762
Closed -$235K 2068
2020
Q4
$235K Sell
10,762
-41,693
-79% -$812K 0.01% 895
2020
Q3
$925K Sell
52,455
-12,612
-19% -$235K 0.1% 208
2020
Q2
$1.22M Buy
65,067
+51,250
+371% +$908K 0.14% 183
2020
Q1
$239K Sell
13,817
-10,695
-44% -$224K 0.11% 79
2019
Q4
$517K Sell
24,512
-2,141
-8% -$43.3K 0.12% 129
2019
Q3
$521K Buy
+26,653
New +$490K 0.15% 90
2019
Q1
Sell
-401
Closed -$6K 1190
2018
Q4
$6K Buy
+401
New +$6.34K ﹤0.01% 608
2018
Q3
Sell
-1,442
Closed -$20K 1077
2018
Q2
$20K Buy
+1,442
New +$19.1K 0.01% 579
2017
Q3
Sell
-2,909
Closed -$37K 963
2017
Q2
$37K Buy
+2,909
New +$38.7K 0.04% 273

Other funds holding MPT

Point72 Hong Kong's MPT Position: Q4 2022 in Review

Point72 Hong Kong sold out of Medical Properties Trust (MPT) in Q4 2022, closing a stake of 28,526 shares — an estimated $338K sold.

Point72 Hong Kong first reported a position in MPT in Q2 2017 and held it in 13 quarters. The position peaked at $1.22M in Q2 2020. 639 funds tracked by Wall St. Rank hold MPT as of Q4 2022.

  • Point72 Hong Kong reported no remaining Medical Properties Trust position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 28,526 Medical Properties Trust shares in Q4 2022, an estimated $338K.
  • Point72 Hong Kong first reported a position in Medical Properties Trust in Q2 2017 and held it in 13 quarters.
  • Point72 Hong Kong's Medical Properties Trust position peaked at $1.22M in Q2 2020.
  • 639 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.